No Data
US Stock MarketDetailed Quotes
IMRN Immuron
Watchlist
1.930
-0.020-1.03% Close 09/22 16:00 ET
1.930High1.920Low1.11KVolume
1.920Open1.950Pre Close2.16KTurnover0.02%Turnover RatioLossP/E (TTM)10.99MMarket Cap3.21052wk HighLossP/E (Static)5.69MShares1.39052wk Low0.79P/B9.19MFloat Cap28.990Historical High--Dividend TTM4.76MShs Float1.390Historical Low--Div YieldTTM0.51%Amplitude1.943Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Immuron Company
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce at mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.
Revenue Breakdown
Business
Unit:AUD
Stock NameYOYOperating income%
HyperImmune Products--765.19K100.00%
News
Immuron Limited Announces Participation in the LD Micro Main Event XVI
Immuron Reports August Sales of A$1.18M From Travelan in Australia
Immuron Sees Nearly 8000% Boost in August Sales of Gastrointestinal Drug
Sales of Immuron's (ASX:IMC) gastrointestinal and digestive health supplement Travelan rose by a substantial 7984% in August to around AU$1.2 million from AU$14,581 during the year-ago period. The pos
Comments
Some of latest alerts🔥🔥 over 700%+ (from 5/8)
Part 2
APLD ENVB CDW CTLT GSIT
GDC SMFL ELGX RETO WISA
ORGO SFWL IBRX IMPP TCRX
PRAA CLRO TRVN MOBQ IMRN
EZFL PACW
$Organogenesis(ORGO.US$$Shengfeng Development(SFWL.US$$ImmunityBio(IBRX.US$$Imperial Petroleum(IMPP.US$$TScan Therapeutics(TCRX.US$$PRA Group(PRAA.US$$ClearOne(CLRO.US$$Trevena(TRVN.US$$Mobiquity Technologies(MOBQ.US$$Immuron(IMRN.US$$EzFill Holdings(EZFL.US$$PacWest Bancorp(PACW.US$
APLD ENVB CDW CTLT GSIT
GDC SMFL ELGX RETO WISA
ORGO SFWL IBRX IMPP TCRX
PRAA CLRO TRVN MOBQ IMRN
EZFL PACW
$Organogenesis(ORGO.US$$Shengfeng Development(SFWL.US$$ImmunityBio(IBRX.US$$Imperial Petroleum(IMPP.US$$TScan Therapeutics(TCRX.US$$PRA Group(PRAA.US$$ClearOne(CLRO.US$$Trevena(TRVN.US$$Mobiquity Technologies(MOBQ.US$$Immuron(IMRN.US$$EzFill Holdings(EZFL.US$$PacWest Bancorp(PACW.US$
+2
4
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
BarfBag : How you feel about PGY?
小觑 BarfBag: PGY这只票正在回调，你也持有吗？
BarfBag 小觑: It’s booming today
小觑 BarfBag: 今天突然放量上涨，真让人措手不及